top of page
Latest News
Search
The False Economy of Rationing Life
States are rationing HIV medications through prior auth and formulary cuts to solve ADAP budget crises — a strategy that costs more, drives resistance, and concentrates harm on the most vulnerable.
Travis Roppolo
Mar 235 min read
The Great American Recovery Needs More Than a Slogan
Administration expands OUD medication access while defunding SAMHSA and restricting harm reduction.
Travis Roppolo
Feb 86 min read
HIV/HCV Co-Infection Watch Q1: January 2026
Q1 2026 Watch: HCV/HIV co-infection treatment access under evolving federal and state policies.
Ranier Simons
Jan 2830 min read
HIV/HCV Co-Infection Watch Q4: October 2025
Q4 2025 Watch monitoring HCV treatment access and federal initiatives including Cure Hepatitis C Act.
Ranier Simons
Oct 29, 202530 min read
HIV/HCV Co-Infection Watch Q3: July 2025
Q3 2025 Watch: critical analysis including Cure Hepatitis C Act proposing subscription treatment models.
Travis Roppolo
Jul 29, 202532 min read
HIV/HCV Co-Infection Watch Q2: April 2025
Q2 2025 Watch monitoring HCV and HIV treatment access through ADAPs, Medicaid, and federal assistance.
Travis Roppolo
Apr 23, 202528 min read
HIV/HCV Co-Infection Watch Q1: January 2025
Q1 2025 Watch: comprehensive update on HIV/HCV co-infection treatment access across federal and state programs.
Travis Roppolo
Jan 27, 202525 min read
Bipartisan Hepatitis C Elimination Plan Presents Critical Lame Duck Opportunity
Bipartisan HCV elimination legislation analysis and critical legislative window.
Travis Roppolo
Nov 17, 20246 min read
HIV/HCV Co-Infection Watch Q4: October 2024
Q4 2024 Watch: HCV treatment access assessment with guidance for disaster-displaced individuals.
Ranier Simons
Oct 27, 202424 min read
Public Input Needed - HIV, STI, Vaccine, and Hepatitis Policies
Call to action for community input on federal health policy initiatives.
Travis Roppolo
Oct 20, 20245 min read
HCV Prevalence Burden Higher Among HIV-Positive MSM
Elevated HCV prevalence among HIV-positive MSM and co-infection management implications.
Travis Roppolo
Aug 25, 20243 min read
The Promise of a Cure - Why Are We Still Failing People with HCV
Systemic barriers preventing HCV-infected people from accessing available cure.
Travis Roppolo
Aug 4, 20247 min read
HIV/HCV Co-Infection Watch Q3: July 2024
Q3 2024 Watch monitoring HCV treatment access across ADAPs, Medicaid, Veterans programs, and assistance initiatives.
Ranier Simons
Jul 29, 202424 min read
Addressing the High Burden of HCV in HIV-Positive MSM
HCV co-infection in HIV-positive MSM: treatment barriers through ADAPs and policy recommendations.
Travis Roppolo
Jul 14, 20248 min read
Equitable and Data-Driven Viral Hepatitis Quality Measures
HHS proposed viral hepatitis quality measures for Medicaid and health equity implications.
Travis Roppolo
May 19, 20245 min read
HIV/HCV Co-Infection Watch Q2: April 2024
Q2 2024 Watch: Prior authorization rollbacks in Medicaid HCV programs; ADAP and assistance program coverage.
Ranier Simons
Apr 28, 202424 min read
HCV Cases Down, But Not Out
Declining HCV infections but persistent treatment barriers and disparities remain.
Travis Roppolo
Apr 21, 20246 min read
Focus on Hepatitis B - WHO's New Guidelines
WHO updated hepatitis B guidelines: implications for global HBV testing and treatment.
Travis Roppolo
Apr 7, 20246 min read
HIV/HCV Co-Infection Watch Q1: January 2024
Q1 2024 Watch: Pandemic Medicaid protections ended; millions lost coverage; ADAP and veterans updates.
Ranier Simons
Jan 29, 202422 min read
CANN Grows to Meet Need
CANN outlines organizational growth and 2024 policy priorities including state-level advocacy.
Jen Laws
Jan 2, 20246 min read
We Need Your Support Today!
bottom of page